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OBJECTIVE: To compare the renal outcome in patients submitted to two different regimens of glycemic control,
using the RIFLE criteria to define acute kidney injury.
INTRODUCTION: The impact of intensive insulin therapy on renal function outcome is controversial. The lack of a
criterion for AKI definition may play a role on that.
METHODS: Included as the subjects were 228 randomly selected, critically ill patients engaged in intensive insulin
therapy or in a carbohydrate-restrictive strategy. Renal outcome was evaluated through the comparison of the last
RIFLE score obtained during the ICU stay and the RIFLE score at admission; the outcome was classified as favorable,
stable or unfavorable.
RESULTS: The two groups were comparable regarding demographic data. AKI developed in 52% of the patients and
was associated with a higher mortality (39.4%) compared with those who did not have AKI (8.2%) (p,0.001). Renal
function outcome was comparable between the two groups (p = 0.37). We observed a significant correlation
between blood glucose levels and the incidence of acute kidney injury (p = 0.007). In the multivariate logistic
regression analysis, only APACHE III scores higher than 60 were identified as an independent risk factor for
unfavorable renal outcome. APACHE III scores.60, acute kidney injury and hypoglycemia were risk factors for
mortality.
CONCLUSION: Intensive insulin therapy and a carbohydrate-restrictive strategy were comparable regarding the
incidence of acute kidney injury evaluated using RIFLE criteria.
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INTRODUCTION
The Van de Berghe et al.1 study (2001) introduced the
concept of strict glycemic control for the critically ill patient,
demanding a new approach in the treatment of hypergly-
cemia in the intensive care unit (ICU). This study demon-
strated that treatment of patients admitted to a surgical ICU
with a regimen of intensive insulin therapy (IIT) resulted in
lower morbidity and mortality compared with those treated
with standard glycemic control. The effect was particularly
significant with regard to renal outcome; patients managed
with IIT had a lower incidence of acute renal failure
(defined as the need for renal replacement therapy [RRT]).
In a subsequent study performed in a medical ICU, Van
den Berghe et al.2 observed that the group treated with IIT
had a lower incidence of newly-acquired acute kidney injury
(AKI), as defined by increases in serum creatinine levels.
On the other hand, the VISEP3 study compared IIT with a
standard glycemic control strategy and did not find that the
use of IIT benefited the renal outcomes of 488 patients.
Moreover, this study was interrupted due to high rates of
hypoglycemia. A meta-analysis that evaluated the impact of
strict glycemic control on the prognosis of critically ill
patients4 did not show a reduced need for RRT. As with the
VISEP study, the meta-analysis showed a higher incidence
of hypoglycemia in patients receiving strict glycemic
control. The NICE-SUGAR Study5 that randomized 6104
patients and compared IIT with a conventional glycemic
control did not find significant differences in the incidence
of acute renal failure defined as the need for RRT.
There has been a lack of consensus regarding the
definition of AKI. Many criteria are used in defining AKI,
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including the need for dialysis as well as changes in serum
creatinine levels, blood ureic nitrogen (BUN) levels and
urinary output. As a consequence, it is difficult to compare
the results produced by these different methods. The
publication of the RIFLE criteria in 20046 had the objective
of standardizing the AKI definition and proposed three
graded levels of injury: Risk (R), Injury (I), Failure (F), and
two outcome stages: Loss (L) and End-stage Kidney Disease
(E). The RIFLE criteria were validated in large trials, making
them a promising prognostic predictor.7–10
Recently, we performed a prospective randomized trial
comparing the safety and efficacy of IIT and a carbohydrate-
restrictive strategy (CRS) in a mixed population of critically
ill patients. We did not find a significant difference in the
rates of incidence of AKI (defined as the need for dialysis)
between the two groups.11 The objective of the present
study was to compare the renal function outcome in the
same group of patients by using the RIFLE criteria to define
AKI.
METHODS
A retrospective analysis of clinical and laboratory data of
patients included in the original prospective trial was
performed. This study included all adult, non-pregnant
patients admitted from July 1, 2004 to December 31, 2006 to
a 20-bed, multidisciplinary ICU in a general hospital and an
11-bed trauma center ICU who had registered at least two
blood glucose levels above 150 mg/dL from three measure-
ments obtained within the first 12 hours of ICU admission.
After written informed consent was obtained, patients were
randomized to one of the glycemic control strategies:
Group 1 (Intensive Insulin Therapy). Continuous intrave-
nous insulin infusion was adjusted to maintain glycemic
levels less than 150 mg/dL; in stable patients levels were
maintained between 80 and 120 mg/dL. Capillary glycemic
measurements were obtained from the patients every two
hours. The insulin dose was adjusted according to an
algorithm run by nurses and overseen by physicians. These
patients received glucosaline (5% glucose + 0.9 NaCl)
hydration and enteral nutrition with a formula containing
45% carbohydrates, 17% proteins and 38% lipids (Diason,
Nutricia Clinical Care Ltd).
Group 2 (Carbohydrate-Restrictive Strategy). Patients
received intravenous hydration with a glucose-free solution
(Ringer III) and enteral nutritional formula containing 33.3%
carbohydrates, 16.7% proteins and 50% lipids (Glucerna,
Abbott Laboratories). These patients received regular
insulin subcutaneously according to a sliding scale with
the goal of maintaining blood glucose levels less than
180 mg/dL; in stable patients, the goal was a level less than
150 mg/dL.
Hypoglycemia was defined as a blood glucose level of
40 mg or less per deciliter.
All patients had their basal creatinine level estimated by
the Modification of Diet in Renal Disease (MDRD)12
equation (glomerular filtration rate [GFR] = 186 6 [serum
creatinine]21.154 6 [age]20.203 6 [0.742 woman] 6 [1.210 if
North American black]), considering an acceptable GFR of
75 ml/min as suggested by the Acute Dialysis Quality
Group (ADQI) in the publication of the RIFLE criteria. We
did not use the variable of race because we were dealing
with a mixed-race population; we also did not include any
subjects self-identifying as North-American black. The
equation with this modification had already been validated
for a Brazilian population.13
The RIFLE category was determined based only on the
GFR estimated by serum creatinine levels. Urinary output
was not used because available data were insufficient for
analysis.
After we recorded all the creatinine levels from the period
of the ICU stay, we determined the RIFLE category on the
first and last days of the ICU stay and on the day that the
patient presented the highest category. For those who had
more than one creatinine value at admission, the highest
level during the first 24 hours was considered. Patients were
classified into four categories: Normal renal function (N),
Risk (R), Injury (I) and Failure (F); the last three categories
defined acute kidney injury. The categories Loss (L) and
End-stage Kidney Disease (E) were not considered in the
present study.
Renal outcomes were evaluated through the comparison
of the last RIFLE category obtained during the ICU stay and
the RIFLE score at admission. Depending on renal outcome,
patients were classified as favorable (last RIFLE better than
that at admission), stable (similar RIFLE categories) and
unfavorable (last RIFLE worse than that admission).
The effect of the two strategies was evaluated only in the
group of patients that stayed longer than three days in the
ICU. Excluded from the study were all patients who had
dialytic chronic renal disease and all patients who had less
than three values of serum creatinine in a period longer than
four days. Excluded patients were considered for intention-
to-treat analysis. The study protocol was approved by the
Ethics Committee of Sa˜o Domingos Hospital.
Statistical analysis:
Our primary endpoint was the renal function outcome.
Mortality and incidence of newly acquired AKI were
secondary endpoints. Data are presented as means ¡
standard deviation or medians with interquartile intervals.
The chi-square test was used to evaluate the association
between categorical variables, and either Student’s t-test or
the Mann-Whitney U-test was used for evaluation of
continuous variables. Multivariate logistic regression ana-
lysis was performed to evaluate the impact of age, sex,
APACHE (Acute Physiology and Chronic Health
Evaluation) III score, diabetes mellitus and hypoglycemia
on unfavorable renal outcome, mortality and AKI. The
impact of unfavorable renal outcome and AKI on mortality
was also analyzed using the same model of logistic
regression. All statistical tests were two-sided and were
considered to be significant at p,0.05. Data were registered
in the statistical analysis program SPSS 14.0.
RESULTS
Of the 337 patients included in the original trial, 265
remained in the ICU longer than three days. Among these
patients, five were excluded for having chronic renal disease
receiving hemodialysis, and 32 were excluded for having less
than three measurements of serum creatinine levels during the
stay. In total, 228 patients were included in the final analysis.
Demographic data, comorbidities and severity
Among the 228 studied patients, 110 (49%) were in group
1 (IIT) and 118 (51%) in group 2 (CRS). There were no
differences between the two groups regarding gender, age,
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previously known diabetes mellitus, APACHE III score and
length of stay (LOS) in the ICU (Table 1). The intention-to-
treat analysis also showed comparable data between the two
groups.
Glycemic control
The median blood glucose levels in the IIT and CRS
groups were 132.6 (119.5–150.7) mg/dL and 142 (123.6–
171.2) mg/dL, respectively (p = 0.02). The median insulin
doses used for glycemic control in groups 1 and 2 were 56.5
(38.8–76.7) IU and 1.3 (0n5.9) IU, respectively (p,0.001). The
occurrence of hypoglycemia was higher in the IIT group (20
patients [18.1%]) than in the CRS group (five patients
[4.2%]), p = 0.001 (Table 2).
Renal function and mortality
The mean basal creatinine levels calculated for both
groups were comparable (Table 3). The RIFLE classification
on admission did not show significant differences between
the two groups (p = 0.78). We observed that 52.1% of the
studied patients presented some level of AKI during their
ICU stay, and there was no difference in distribution
between the two groups (p = 0.91). AKI was more frequent
in diabetic patients (69.5%) than in non-diabetics (43.9%)
(p,0.001). Thirty patients needed dialysis: 17 in group 1 and
13 in group 2 (p = 0.56).
Renal outcomes were comparable between the two
groups (p = 0.37) (Table 3). In contrast, we observed a
significant correlation between the blood glucose levels and
the incidence of AKI (p = 0.007) (Table 4).
Of the 228 patients included in the study, 56 (24.5%) died:
24 in group 1 and 32 in group 2 (p = 0.35). Mortality was
higher for patients with unfavorable renal outcome (43.2%)
compared to those with stable or favorable renal outcome
(20.9%) (p = 0.004). Mortality was also higher in patients
who presented some level of acute kidney injury (39.2%)
compared to those with normal renal function (8.2%)
(p,0.001).
In the multivariate logistic regression analysis, only an
APACHE III score higher than 60 was identified as an
independent risk factor for unfavorable renal outcome.
Previous diabetes mellitus and APACHE III scores higher
than 60 were risk factors for AKI. Hypoglycemia, APACHE
III score.60 and AKI were risk factors for mortality
(Table 5).
DISCUSSION
Our comparison of two strategies of glycemic control in a
mixed population of critically ill patients did not show a
significant difference in the incidence and severity of acute
kidney injury evaluated using RIFLE criteria. However, we
observed that an increase in blood glucose levels beyond
normal values was associated with increased incidence of
AKI.
In a previous study in which we compared the safety and
efficacy of intensive insulin therapy with a carbohydrate-
restrictive strategy, we used the need for dialysis as the
criterion to define renal dysfunction, and no difference was
observed between the two groups. The present study used a
more accurate and sensitive tool, the RIFLE criteria, that
includes a wide spectrum of renal dysfunction and not
merely the more severe forms of the disease.
Although Van den Berghe et al.1 showed a significant
reduction in the incidence of acute renal failure in patients
submitted to intensive insulin therapy, these authors used




n = 118 p Value
Age (y)
Mean ¡ SD 58.7 ¡ 20.4 55.5 ¡ 21.6 0.25
Female, n (%) 48 (43.6) 59 (50) 0.33
APACHE III score
Mean ¡ SD 69.2 ¡ 22.5 67.1 ¡ 26.9 0.54
ICU LOS, days
Median 10 10.5
Interquartile range 6–22 7–18.5 0.87
Previous diabetes mellitus
n (%) 39 (35.4) 30 (25.4) 0.11
APACHE: Acute Physiology and Chronic Health Evaluation; ICU: Intensive
Care Unit; LOS: length of stay.




n = 118 p Value
Blood glucose levels (mg/dl)
Median 132.6 142
Interquartile range 119.5–150.7 123.6–171.2 0.02
Insulin dose (IU/d)
Median 56.5 1.3
Interquartile range 38.8–76.7 0–5.9 ,0.001
Hypoglycemia, n (%) 20 (18.8) 5 (4.2) 0.001










Mean ¡ SD 0.984 ¡ 0.146 0.980 ¡ 0.170 0.89
Admission RIFLE
(n) normal 70 78
Risk 15 18 0.78
Injury 11 8
Failure 10 12
Acute kidney injury n (%) 57 (51.8) 62 (52.5) 0.91
Renal function outcome
Unfavorable 17 20
Stable 64 76 0.37
Favorable 29 22
Table 4 - Acute kidney injury according to glycemic levels.
Glycemia Normal Kidney Injury Total
, 120 33 (60,0) 22 (40,0) 55 (24,1)
120 a 150 49 (51,6) 46 (48,4) 95 (41,7)
150 a 180 19 (43,2) 25 (56,8) 44 (19,3)
. 180 8 (23,5) 26 (76,5) 34 (14,9)
Total 109 (47,8) 119 (52,2) 228
p = 0.007
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the need for dialysis as the criterion to define acute renal
failure. This restricts the analysis to patients with severe
renal dysfunction.
The lack of consensus regarding the definition of acute
renal failure that lasted until recently created difficulties in
evaluating the effects of different therapeutic interventions
on the incidence and severity of acute kidney injury. The
publication of the RIFLE criteria in 20045 that standardized
the definition of AKI was followed by studies with large
patient populations that validated those criteria, creating a
tool that unified the diagnosis of AKI. RIFLE allowed the
analysis of AKI’s full spectrum of severity and not just the
most severe forms of the disease.
Lecomte et al.14 were the first to use the RIFLE criteria to
compare AKI incidence in patients who had been submitted
to two different strategies of glycemic control. This study
showed that, in non-diabetic patients undergoing cardiac
surgery, strict glycemic control during and after surgery
was associated with a significant decrease in AKI and
mortality, with a minimal incidence of hypoglycemia
(0.17%). Rather than analyzing patients in the perioperative
period, our study included only patients that remained in
the ICU for at least three days. We based our strategic focus
on that of the Van den Berghe et al. study,2 which affirmed
that intensive insulin therapy requires a minimal period of
time to have an effect and that more benefits are observed
after three days of intervention.
Recently, the Acute Kidney Injury Network (AKIN)15
proposed a modification of the RIFLE criteria with the
objective of increasing its sensitivity. Studies that have
compared the two sets of criteria have shown little
difference between them.16,17
In this study, the carbohydrate-restrictive strategy was
comparable to intensive insulin therapy in terms of effects on
the incidence of AKI. However, the CRS group had a
significantly lower incidence of hypoglycemia. It is well
documented that hypoglycemia is associated with higher
mortality and neurologic dysfunction. In the Van den Berghe
study2, the logistic regression analysis identified hypoglyce-
mia as an independent risk factor for death. The multicenter
GLUCONTROL18 study was interrupted prematurely because
of this kind of risk. The interruption was required because of
the high incidence of hypoglycemia and the significantly
higher mortality in patients that presented with this complica-
tion. In the present study, multivariate regression analysis
showed that hypoglycemia was a risk factor for death.
The incidence of AKI in the patients in our sample was
high (52%) when compared to that observed by Ostermann
et al.7 (38.5%), who also observed patients in an ICU. Uchino
et al.6 observed a smaller incidence of AKI (18%) when they
analyzed all the patients admitted to a tertiary university
hospital. Like our own study, both of these studies showed a
significant impact of AKI (as defined by the RIFLE criteria)
on mortality. The multivariate logistic regression analysis of
our study reinforced that AKI is an independent risk factor
for death.
This study has some limitations. It is a retrospective
analysis of patients that were included in a prospective
randomized trial. Some patients were excluded from the
analysis because they had less than three creatinine
determinations during their ICU stay. It is also worth
noting that because rigorous measurements of urine output
were not required in the original trial, RIFLE classification
was based only on serum creatinine levels. It is not possible
to state whether the measurement of urine output would
have changed the results of this study. Some studies suggest
that patients who had a RIFLE classification based on
creatinine values were more severely ill than patients in the
same risk category whose classification was defined by
urine volume alone.19 The studies by Uchino et al.7 and
Ostermann et al.8 also defined RIFLE category based only
on serum creatinine.
CONCLUSION
Intensive insulin therapy and a carbohydrate-restrictive
strategy were comparable in their effects on the incidence of
acute kidney injury evaluated using the RIFLE criteria.
However, we observed that an increase in the blood glucose
levels beyond normal values was associated with an
increase in the incidence of AKI. This finding, as well as
the higher incidence of hypoglycemia, suggests that a
carbohydrate-restrictive strategy is safer than and as
efficient as intensive insulin therapy in preventing acute
kidney injury in critically ill patients.
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